@article{article, title  = {{182P Radium-223 (223Ra) in combination with exemestane and everolimus (EXE-EVE) in patients (pts) with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer (MBC) with bone metastases: A phase II study}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2022}},

 month = {{5}},

 author = {{Rugo HS and Drumea K and Lee SC and Campone M and Van Poznak C and Neven P and Vega Alonso E and Naume B and Siegel JM and Li R and Uema D et al}},

 doi = {{10.1016/j.annonc.2022.03.201}},

 volume = {{33}},

 journal = {{Annals of Oncology}},

 pages = {{S211-S212}},

 note = {{Accessed on 2025/10/10}}}